Suchergebnisse - "Plumb, Ian D"

PubPharm (59)

1

Effectiveness of a bivalent mRNA vaccine dose against symptomatic SARS-CoV-2 infection among U.S. Healthcare personnel, September 2022-May 2023

enthalten in: Vaccine | 2024

von Plumb, I. | Briggs Hagen, M. | Wiegand, R. | +39

2

Sociodemographic and Occupational Characteristics Associated with Early and Continued COVID-19 Vaccine Uptake Among Healthcare Personnel : Monroe County, NY

enthalten in: Vaccine | 2024

von Russ, S. | Myers, C. | Licherdell, E. | +6

3

Clinical and laboratory characteristics of patients hospitalized with severe COVID-19 in New Orleans, August 2020 to September 2021

enthalten in: Scientific reports | 2024

von Drouin, A. | Plumb, I. | McCullough, M. | +10

4

Combined protection of vaccination and nirmatrelvir-ritonavir against hospitalization in adults with COVID-19

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2024

von Shah, M. | Joyce, B. | Plumb, I. | +8

5

Factors associated with the decision to receive bivalent COVID-19 booster vaccination among health care personnel

enthalten in: Human vaccines & immunotherapeutics | 2023

von Mohr, N. | Plumb, I. | Santos León, E. | +6

6

Healthcare providers' knowledge and clinical practice surrounding shigellosis - DocStyles Survey, 2020

enthalten in: BMC primary care | 2023

von Haston, J. | Ford, L. | Vanden Esschert, K. | +4

7

Healthcare providers’ knowledge and clinical practice surrounding shigellosis — DocStyles Survey, 2020

enthalten in: BMC family practice | 2023

von Haston, J. | Ford, L. | Vanden Esschert, K. | +4

8

Effectiveness of a Messenger RNA Vaccine Booster Dose Against Coronavirus Disease 2019 Among US Healthcare Personnel, October 2021-July 2022

enthalten in: Open forum infectious diseases | 2023

von Plumb, I. | Mohr, N. | Hagen, M. | +34

9

Antimicrobial-Resistant Nontyphoidal Salmonella Infection Following International Travel-United States, 2018-2019

enthalten in: The Journal of infectious diseases | 2023

von Ford, L. | Shah, H. | Eikmeier, D. | +6

10

Prevalence of Symptoms ≤12 Months After Acute Illness, by COVID-19 Testing Status Among Adults - United States, December 2020-March 2023

enthalten in: MMWR. Morbidity and mortality weekly report | 2023

von Montoy, J. | Ford, J. | Yu, H. | +89

1
2
3
4
5
6
Nächster »
[6]